Soluble forms of immune checkpoint receptor PD-1 and its ligand PD-L1 in plasma of patients with ovarian neoplasms

by E. S. Gershtein, D. O. Utkin, I. O. Goryacheva, M. M. Khulamkhanova, N. A. Petrikova, I. I. Vinogradov, A. A. Alferov, I. S. Stilidi, N. E. Kushlinskii
Published 2018-12-01

Hypermethylation of the microRNA miR-124, miR-125b, miR-127, and miR-129 in ovarian carcinoma is involved in suppression of their expression and associated with both the developmen...

by E. A. Braga, I. V. Pronina, D. O. Utkin, E. A. Filippova, A. M. Burdennyy, V. I. Loginov, M. V. Fridman, T. P. Kazubskaya, N. E. Kushlinskii
Published 2019-02-01

Comparative analysis of serum and tumor vascular endothelial growth factor, insulin-like growth factor 1, matrix metalloproteinase 7 levels in patients with ovarian cancer

by Ya. Z. Plieva, V. D. Ermilova, I. V. Tereshkina, D. N. Kushlinskiy, V. M. Shelepova, D. O. Utkin, S. V. Khokhlova, E. K. Dvorova, Yu. G. Payanidi, K. I. Zhordania
Published 2018-01-01